Loading...
•
Dec 31, 2022
HCA Q4 2022 Earnings Report
HCA Healthcare's financial performance in Q4 2022 showed increased revenues and net income compared to the same period last year, with same facility admissions and equivalent admissions also increasing.
Key Takeaways
HCA Healthcare reported a strong fourth quarter in 2022, with revenues totaling $15.497 billion and net income attributable to HCA Healthcare, Inc. reaching $2.081 billion, or $7.28 per diluted share. The company's performance benefited from increased same facility admissions and equivalent admissions.
Revenues totaled $15.497 billion.
Net income attributable to HCA Healthcare, Inc. totaled $2.081 billion, or $7.28 per diluted share.
Adjusted EBITDA totaled $3.179 billion.
Cash flows from operating activities totaled $2.527 billion.
Same facility admissions increased 2.9 percent while same facility equivalent admissions increased 5.4 percent
Forward Guidance
The Company issued the following estimated guidance for 2023:
Positive Outlook
- Revenues $61.5 to $63.5 billion
- Net Income Attributable to HCA Healthcare, Inc. $4.525 to $4.895 billion
- Adjusted EBITDA $11.8 to $12.4 billion
- EPS (diluted) $16.40 to $17.60 per diluted share
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...